logo labmar

Plantagen C

C.N.193176.4

Composição

500 mg de CurQfen® (350 mg de extracto de cúrcuma (Curcuma longa L.rizoma) com 175 mg de curcuminoides, combinado com 150 mg de galactomananos de Fenogrego (Trigonella foenum-
graecum L.).

Excipientes: maltodextrina, dióxido de silicio. Cápsula de gelatina.

(Composição por cápsula)

41,10 

Advertências

Hipersensibilidade a algum dos componentes

Forma de apresentação

Frasco com 60 cápsulas.

Bibliografia

1.- Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998; 64:1167-1172.

2.- Surh YJ, Chun KS, Cha HH, y cols. Molecular mechanisms underlying chemo-preventive activities of anti-inflammatory phytochemicals: downregulation of COX-2 and iNOS through suppression of NF-?B activation. Mutation Research 2001; 480-481:243-268.

3.- Dunsmore KE, Chen PG, Wong HR. Curcumin, a medicinal herbal compound capable of inducing the heat shock response. Crit Care Med 2001; 29:2199-2204.

4.- Chang D-M. Curcumin: a heat shock response inducer and potential cytoprotector. Crit Care Med 2001; 29; 2231-2232.

5.- Jovanovic SV, Boone CW, Steenken S, Trinoga M, Kaskey RB. How curcumin preferentially works with water soluble antioxidants. J Am Chem Soc 2001; 123:3064-3068.

6.- Gaedeke J, Noble NA, Border WA. Curcumin blocks multiple sites of the TGF-? signaling cascade in renal cells. Kidney International 2004; 66:112-120.

7.- Srinisan P, Libbus B. Mining MEDLINE for implicit links between dietary substances and diseases. Bioinformatics 2004; 20:1290-1296.

8.- Akhilender Naidu K, Thippeswamy NB. Inhibition of human low density lipoprotein oxidation by active principles from spices. Mol Cell Biochem 2002; 229:19-23.